Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.09%592.09M | 8.67%597.13M | 1.38%542.51M | -2.46%2.18B | 3.10%530.81M | 1.82%568.82M | -6.22%549.49M | -7.71%535.14M | -13.19%2.24B | -10.42%514.86M |
| Operating revenue | 4.09%592.09M | 8.67%597.13M | 1.38%542.51M | -2.46%2.18B | 3.10%530.81M | 1.82%568.82M | -6.22%549.49M | -7.71%535.14M | -13.19%2.24B | -10.42%514.86M |
| Cost of revenue | 4.08%465.67M | 8.55%467.04M | 2.07%425.53M | -3.55%1.71B | 2.99%415.58M | 1.61%447.44M | -7.76%430.27M | -9.93%416.9M | -12.34%1.77B | -12.01%403.51M |
| Gross profit | 4.15%126.42M | 9.12%130.09M | -1.06%116.98M | 1.71%474.06M | 3.48%115.23M | 2.60%121.38M | -0.19%119.22M | 1.06%118.23M | -16.28%466.1M | -4.15%111.35M |
| Operating expense | 5.03%101.55M | -3.94%88.59M | 6.51%99.95M | 0.90%377.16M | 9.67%94.42M | -4.14%96.69M | -2.33%92.22M | 1.52%93.84M | 3.80%373.8M | -5.98%86.09M |
| Selling and administrative expenses | 3.82%82.38M | -8.57%69.71M | 5.20%81.41M | -0.44%308.86M | 8.02%75.88M | -6.96%79.35M | -2.28%76.24M | 0.94%77.39M | -8.45%310.23M | -18.38%70.25M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.94%77.39M | ---- | ---- |
| Depreciation amortization depletion | 10.57%19.17M | 18.16%18.88M | 12.68%18.53M | 7.43%68.29M | 17.00%18.53M | 11.31%17.34M | -2.56%15.98M | 4.38%16.45M | 199.05%63.57M | 187.98%15.84M |
| -Depreciation and amortization | 10.57%19.17M | 18.16%18.88M | 12.68%18.53M | 7.43%68.29M | 17.00%18.53M | 11.31%17.34M | -2.56%15.98M | 4.38%16.45M | 199.05%63.57M | 187.98%15.84M |
| Operating profit | 0.70%24.87M | 53.73%41.51M | -30.19%17.03M | 4.99%96.91M | -17.61%20.81M | 41.55%24.7M | 7.87%27M | -0.68%24.4M | -53.06%92.31M | 2.67%25.26M |
| Net non-operating interest income (expenses) | -8.74%-11.37M | -16.57%-12.44M | -4.80%-11.31M | 12.36%-42.49M | 10.55%-10.57M | 14.02%-10.45M | 11.87%-10.67M | 11.67%-10.79M | -39.68%-48.48M | 17.80%-11.82M |
| Non-operating interest income | 181.21%883K | ---- | ---- | ---- | ---- | 74.44%314K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 17.81%11.17M | 20.12%11.49M | 6.96%10.42M | -11.55%38.43M | -7.84%9.64M | -12.75%9.48M | -13.18%9.56M | -12.26%9.74M | 22.35%43.45M | -28.68%10.46M |
| Total other finance cost | -16.04%1.08M | -14.09%951K | -15.22%891K | -19.30%4.06M | -72.43%217K | -12.53%1.28M | 1.37%1.11M | -22.03%1.05M | --5.03M | --787K |
| Other net income (expenses) | 167.94%534K | -702.00%-1.51M | 115.09%43K | 194.28%874K | 382.50%1.7M | -55.95%-786K | 250K | -285K | -209.83%-927K | -197.56%-600K |
| Gain on sale of security | 167.94%534K | -702.00%-1.51M | 115.09%43K | 194.28%874K | 382.50%1.7M | -55.95%-786K | --250K | ---285K | -209.83%-927K | -197.56%-600K |
| Income before tax | 4.30%14.04M | 66.24%27.56M | -56.73%5.76M | 28.89%55.29M | -7.07%11.94M | 181.23%13.46M | 28.29%16.58M | 7.90%13.32M | -73.64%42.9M | 18.47%12.84M |
| Income tax | 27.37%3.89M | 1,354.48%5.46M | -37.96%1.64M | 28.68%8.82M | -7.77%3.55M | 192.52%3.05M | -112.23%-435K | -3.60%2.65M | -79.91%6.85M | 250.94%3.85M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2.47%10.15M | 29.92%22.11M | -61.39%4.12M | 28.93%46.48M | -6.77%8.39M | 28.65%10.4M | 81.64%17.02M | 11.19%10.67M | -71.98%36.05M | -32.80%9M |
| Net income continuous operations | -2.47%10.15M | 29.92%22.11M | -61.39%4.12M | 28.93%46.48M | -6.77%8.39M | 28.65%10.4M | 81.64%17.02M | 11.19%10.67M | -71.98%36.05M | -32.80%9M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -2.47%10.15M | 29.92%22.11M | -61.39%4.12M | 28.93%46.48M | -6.77%8.39M | 28.65%10.4M | 81.64%17.02M | 11.19%10.67M | -71.98%36.05M | -32.80%9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2.47%10.15M | 29.92%22.11M | -61.39%4.12M | 28.93%46.48M | -6.77%8.39M | 28.65%10.4M | 81.64%17.02M | 11.19%10.67M | -71.98%36.05M | -32.80%9M |
| Diluted earnings per share | 0.00%0.42 | 20.27%0.89 | -66.67%0.16 | 21.12%1.95 | -17.50%0.33 | 16.67%0.42 | 76.19%0.74 | 11.63%0.48 | -70.73%1.61 | -34.43%0.4 |
| Basic earnings per share | 0.00%0.41 | 20.55%0.88 | -65.96%0.16 | 20.75%1.92 | -20.00%0.32 | 13.89%0.41 | 73.81%0.73 | 11.90%0.47 | -70.93%1.59 | -34.43%0.4 |
| Dividend per share | 7.33%0.1085 | 5.89%0.1085 | -0.93%0.1035 | 6.31%0.4086 | 7.08%0.1007 | 3.06%0.1011 | 7.62%0.1024 | 7.55%0.1045 | 4.59%0.3844 | 6.61%0.094 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.